Movano secures strategic investment from a tier-one medical device company

Movano Health secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and commercialization. “Attracting strategic investment underscores the vast potential of Movano Health’s innovative approach to delivering medical-grade data to both consumers and enterprises. This is a significant endorsement of our technological expertise and our vision to set new standards in the possibilities of what wearable health technology can do,” said John Mastrototaro, CEO of Movano Health. “Our prestigious partner is keenly interested in the potential of our proprietary mmWave radio frequency technology, which demonstrated strong clinical accuracy in a cuffless blood pressure study late last year.”